Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation.
Minerva Cardiol Angiol
; 70(5): 537-544, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-33703853
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Telangiectasia, Hereditary Hemorrhagic
/
Thromboembolism
/
Atrial Appendage
/
Stroke
Type of study:
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Minerva Cardiol Angiol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: